Misha Mehta is a leader in strategic healthcare management and patient advocacy. As Co-Founder and President of Neev Kolte & Brave Ronil Foundation, she has significantly improved patient engagement and outcomes in rare diseases, particularly childhood cancer. Misha has developed key initiatives for childhood cancer communities and advocated for a childhood cancer-specific chapter in the California State Cancer Control Plan. Her expertise in patient advocacy has led to speaking engagements at the White House Cancer Moonshot Initiative. Misha’s background as a Principal Scientist at Roche Molecular Systems and her current role as Program Director at N of 1 Learning Hub have equipped her with valuable skills in clinical trial design and healthcare data management.
New Name, Same Commitment to Rare Diseases
The EveryLife Foundation for Rare Diseases has become The RARE Foundation! Read more about our new brand and how it unifies our advocacy work on behalf of the rare disease community.
